165 related articles for article (PubMed ID: 27462920)
1. Over-expression of ASIC1a promotes proliferation via activation of the β-catenin/LEF-TCF axis and is associated with disease outcome in liver cancer.
Jin C; Yuan FL; Gu YL; Li X; Liu MF; Shen XM; Liu B; Zhu MQ
Oncotarget; 2017 Apr; 8(16):25977-25988. PubMed ID: 27462920
[TBL] [Abstract][Full Text] [Related]
2. Liver cancer: WISP3 suppresses hepatocellular carcinoma progression by negative regulation of β-catenin/TCF/LEF signalling.
Gao H; Yin FF; Guan DX; Feng YX; Zheng QW; Wang X; Zhu M; Zhang XL; Cheng SQ; Chen TW; Jiang H; Zhang EB; Wang JJ; Ni QZ; Yuan YM; Zhang FK; Ma N; Cao HJ; Wang YK; Li JJ; Xie D
Cell Prolif; 2019 May; 52(3):e12583. PubMed ID: 30793395
[TBL] [Abstract][Full Text] [Related]
3. YEATS4 promotes the tumorigenesis of pancreatic cancer by activating beta-catenin/TCF signaling.
Jixiang C; Shengchun D; Jianguo Q; Zhengfa M; Xin F; Xuqing W; Jianxin Z; Lei C
Oncotarget; 2017 Apr; 8(15):25200-25210. PubMed ID: 28445953
[TBL] [Abstract][Full Text] [Related]
4. Connective tissue growth factor is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenicity through beta-catenin-T-cell factor/Lef signaling.
Deng YZ; Chen PP; Wang Y; Yin D; Koeffler HP; Li B; Tong XJ; Xie D
J Biol Chem; 2007 Dec; 282(50):36571-81. PubMed ID: 17951630
[TBL] [Abstract][Full Text] [Related]
5. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.
Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J
J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171
[TBL] [Abstract][Full Text] [Related]
6. Involvement of acid-sensing ion channel 1a in gastric carcinoma cell migration and invasion.
Chen X; Sun X; Wang Z; Zhou X; Xu L; Li F; Zhang X; Pan J; Qi L; Qian H; Mao Z
Acta Biochim Biophys Sin (Shanghai); 2018 May; 50(5):440-446. PubMed ID: 29584803
[TBL] [Abstract][Full Text] [Related]
7. PI3-kinase/Akt pathway-regulated membrane transportation of acid-sensing ion channel 1a/Calcium ion influx/endoplasmic reticulum stress activation on PDGF-induced HSC Activation.
Zuo L; Zhu Y; Hu L; Liu Y; Wang Y; Hu Y; Wang H; Pan X; Li K; Du N; Huang Y
J Cell Mol Med; 2019 Jun; 23(6):3940-3950. PubMed ID: 30938088
[TBL] [Abstract][Full Text] [Related]
8. CARF activates beta-catenin/TCF signaling in the hepatocellular carcinoma.
Fan X; Ma X; Cui L; Dang S; Qu J; Zhang J; Wang X; Mao Z
Oncotarget; 2016 Dec; 7(49):80404-80414. PubMed ID: 27829235
[TBL] [Abstract][Full Text] [Related]
9. ASIC1a stimulates the resistance of human hepatocellular carcinoma by promoting EMT via the AKT/GSK3β/Snail pathway driven by TGFβ/Smad signals.
Zhang Y; Cao N; Gao J; Liang J; Liang Y; Xie Y; Zhou S; Tang X
J Cell Mol Med; 2022 May; 26(10):2777-2792. PubMed ID: 35426224
[TBL] [Abstract][Full Text] [Related]
10. Acid sensor ASIC1a induces synovial fibroblast proliferation via Wnt/β-catenin/c-Myc pathway in rheumatoid arthritis.
Xu Y; Lu Z; Ling Y; Hou R; Tao J; Deng G; Xu X; Chen X; Ruan J; Zhang Y; Peng X; Chen F
Int Immunopharmacol; 2022 Dec; 113(Pt A):109328. PubMed ID: 36279671
[TBL] [Abstract][Full Text] [Related]
11. Cell cycle-related kinase is a direct androgen receptor-regulated gene that drives β-catenin/T cell factor-dependent hepatocarcinogenesis.
Feng H; Cheng AS; Tsang DP; Li MS; Go MY; Cheung YS; Zhao GJ; Ng SS; Lin MC; Yu J; Lai PB; To KF; Sung JJ
J Clin Invest; 2011 Aug; 121(8):3159-75. PubMed ID: 21747169
[TBL] [Abstract][Full Text] [Related]
12. CDK7 activated beta-catenin/TCF signaling in hepatocellular carcinoma.
Duan J; He Y; Fu X; Deng Y; Zheng M; Lu D
Exp Cell Res; 2018 Sep; 370(2):461-467. PubMed ID: 29981747
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of LARGE1 in progression of liver cancer and the underlying mechanism.
Wang M; Tao H; Huang P
Gene; 2021 May; 779():145493. PubMed ID: 33588034
[TBL] [Abstract][Full Text] [Related]
14. Glycogen synthase kinase 3 beta inhibits microRNA-183-96-182 cluster via the β-Catenin/TCF/LEF-1 pathway in gastric cancer cells.
Tang X; Zheng D; Hu P; Zeng Z; Li M; Tucker L; Monahan R; Resnick MB; Liu M; Ramratnam B
Nucleic Acids Res; 2014 Mar; 42(5):2988-98. PubMed ID: 24335145
[TBL] [Abstract][Full Text] [Related]
15. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells.
Sinner D; Kordich JJ; Spence JR; Opoka R; Rankin S; Lin SC; Jonatan D; Zorn AM; Wells JM
Mol Cell Biol; 2007 Nov; 27(22):7802-15. PubMed ID: 17875931
[TBL] [Abstract][Full Text] [Related]
16. Combined Chibby and β-Catenin Predicts Clinical Outcomes in Patients with Hepatocellular Carcinoma.
Tsai MC; Huang CC; Wei YC; Liu TT; Lin MT; Yi LN; Lin PR; Wang CC; Chu TH; Hsiao CC; Hu TH; Tai MH
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192213
[TBL] [Abstract][Full Text] [Related]
17. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription.
Torres VA; Tapia JC; Rodriguez DA; Lladser A; Arredondo C; Leyton L; Quest AF
Mol Cell Biol; 2007 Nov; 27(21):7703-17. PubMed ID: 17785436
[TBL] [Abstract][Full Text] [Related]
18. Beta-catenin/Tcf-4 inhibition after progastrin targeting reduces growth and drives differentiation of intestinal tumors.
Pannequin J; Delaunay N; Buchert M; Surrel F; Bourgaux JF; Ryan J; Boireau S; Coelho J; Pélegrin A; Singh P; Shulkes A; Yim M; Baldwin GS; Pignodel C; Lambeau G; Jay P; Joubert D; Hollande F
Gastroenterology; 2007 Nov; 133(5):1554-68. PubMed ID: 17920061
[TBL] [Abstract][Full Text] [Related]
19. PDZ binding kinase, regulated by FoxM1, enhances malignant phenotype via activation of β-Catenin signaling in hepatocellular carcinoma.
Yang YF; Pan YH; Cao Y; Fu J; Yang X; Zhang MF; Tian QH
Oncotarget; 2017 Jul; 8(29):47195-47205. PubMed ID: 28525379
[TBL] [Abstract][Full Text] [Related]
20. Axin downregulates TCF-4 transcription via beta-catenin, but not p53, and inhibits the proliferation and invasion of lung cancer cells.
Yang LH; Xu HT; Han Y; Li QC; Liu Y; Zhao Y; Yang ZQ; Dong QZ; Miao Y; Dai SD; Wang EH
Mol Cancer; 2010 Feb; 9():25. PubMed ID: 20122174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
